Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FUQNW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,223
Award facts
- Contract value 100% obligated
- $12,222.69 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Zepbound 2.5 mg/0.5 ml pen injectors with a firm fixed price of $12,222.69 and completion deadline of September 23, 2025. This non-competitive delivery order represents a single-unit transaction executed under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle running through December 2026. The product will be fulfilled from AmerisourceBergen's Corporate Office operations in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, maintains an extensive portfolio of delivery orders with the DLA covering diverse pharmaceutical products including specialty medications, biologics, and medical supplies across multiple therapeutic domains. The Troop Support Medical contract vehicle enables the company to supply pharmaceutical products supporting military healthcare programs worldwide, with the DLA planning future multiple-award contracts under its Pharmaceutical Prime Vendor Global Program Generation V initiative. This delivery order for Zepbound, a diabetes and weight management medication, reflects AmerisourceBergen's role in supporting Defense Health Agency medical supply chains for military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FUQNW?
SPE2DB25FUQNW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 22, 2025.
How much is contract SPE2DB25FUQNW worth?
The government has obligated $12,223 on SPE2DB25FUQNW.
Is contract SPE2DB25FUQNW an order under another contract?
Yes. SPE2DB25FUQNW is a delivery order under SPE2DB25D3404, an indefinite delivery contract.
Was contract SPE2DB25FUQNW competed?
The extent of competition for SPE2DB25FUQNW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award